Judges allow consolidation of vision loss lawsuits filed against Novo Nordisk and Eli Lilly over diabetes and weight loss ...
Share on Pinterest Research on GLP-1 drugs and eye health has been inconsistent, but experts say the risk of serious eye disease is generally low. Getty Images/Hiraman Studies have linked GLP-1 ...
Headlines warning about “Ozempic blindness” may be frightening to the millions of people taking a GLP-1 drug to treat Type 2 diabetes or for weight loss. It's not an official diagnosis, but an ...
GLP-1 weight loss drugs have known side effects. Some users experience nausea, others constipation. But now another potential side effect has been thrown into the spotlight, literally, by global ...
Vision Marine Technologies shares fell 13.43% in after-hours trading after the company filed a dilutive offering with the SEC ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results